Alar Pharmaceuticals Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 600,000. Operating loss was TWD 170.765 million compared to TWD 61.389 million a year ago. Net loss was TWD 142.797 million compared to TWD 67.970 million a year ago. Basic loss per share from continuing operations was TWD 2.86 compared to TWD 1.94 a year ago.